Drug recall · March 25, 2020
Sotalol HCL Tablets recall
Why: Presence of particulate matter. presence of metal particles.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sotalol HCL Tablets, USP (AF) 80 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA. NDC 00378-5123-01
- Lots / codes
Lot # 3095754, exp. date 02/2021
- Quantity
- 300 100-count bottles
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Distributed Nationwide in the USA
- Initiated
- March 9, 2020 · Voluntary: Firm initiated
- Classified
- March 18, 2020
- Reported
- March 25, 2020
- Ended
- May 26, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sotalol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.